I agree that this site is using cookies. You can find further informations here.
X
Giménez-Arnau, A.
798  results:
Search for persons X
?
1

Fast symptom improvement and favorable safety profile with ..:

Bérard, F. ; Saini, S. ; Giménez-Arnau, A....
Revue Française d'Allergologie.  64 (2024)  - p. 103855 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Remibrutinib did not impact on total serum immunoglobulin l..:

Bernier, C. ; Carr, W. ; Giménez-Arnau, A....
Revue Française d'Allergologie.  64 (2024)  - p. 103856 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Analysis of safety data of remibrutinib from completed phas..:

Bérard, F. ; Saini, S. ; Maurer, M....
Revue Française d'Allergologie.  64 (2024)  - p. 103861 , 2024
Link: https://doi.org/10.1016/..
 
?
4

REMIBRUTINIB DID NOT IMPACT ON TOTAL SERUM IMMUNOGLOBULIN L..:

Carr, W. ; Gimenez-Arnau, A. ; Lheritier, K....
Annals of Allergy, Asthma & Immunology.  131 (2023)  5 - p. S31 , 2023
Link: https://doi.org/10.1016/..
 
?
5

REMIBRUTINIB SHOWED GOOD STABILITY OF RESPONSE IN PATIENTS ..:

Tillinghast, J. ; Jain, V. ; Maurer, M....
Annals of Allergy, Asthma & Immunology.  131 (2023)  5 - p. S41 , 2023
Link: https://doi.org/10.1016/..
 
?
6

REMIBRUTINIB TREATMENT IMPROVES HIVE SEVERITY IN PATIENTS W..:

Sitz, K. ; Giménez-Arnau, A. ; Hayama, K....
Annals of Allergy, Asthma & Immunology.  131 (2023)  5 - p. S11 , 2023
Link: https://doi.org/10.1016/..
 
?
7

REMIBRUTINIB TREATMENT HAS NO IMPACT ON BLOOD COUNTS IN PAT..:

Leflein, J. ; Hide, M. ; Lheritier, K....
Annals of Allergy, Asthma & Immunology.  131 (2023)  5 - p. S35 , 2023
Link: https://doi.org/10.1016/..
 
?
8

REMIBRUTINIB PROVIDES FAST AND CLINICALLY IMPORTANT IMPROVE..:

Jacobs, J. ; Maurer, M. ; Giménez-Arnau, A....
Annals of Allergy, Asthma & Immunology.  131 (2023)  5 - p. S34-S35 , 2023
Link: https://doi.org/10.1016/..
 
?
9

[Artículo traducido]Esteatohepatitis asociada a omalizumab:

Barbosa, J. ; Coelho, M. ; Brasileiro, A..
Actas Dermo-Sifiliográficas.  114 (2023)  7 - p. T650-T651 , 2023
Link: https://doi.org/10.1016/..
 
?
10

ANALYSIS OF SAFETY DATA OF REMIBRUTINIB FROM COMPLETED PHAS..:

Saini, S. ; Maurer, M. ; Giménez-Arnau, A....
Annals of Allergy, Asthma & Immunology.  131 (2023)  5 - p. S30-S31 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Omalizumab-Associated Steatohepatitis:

Barbosa, J. ; Coelho, M. ; Brasileiro, A..
Actas Dermo-Sifiliográficas.  114 (2023)  7 - p. 650-651 , 2023
Link: https://doi.org/10.1016/..
 
?
12

REMIBRUTINIB ACHIEVES CLINICALLY SIGNIFICANT RESPONSE IN CH..:

Clore, L. ; Maurer, M. ; Wells, M....
Annals of Allergy, Asthma & Immunology.  131 (2023)  5 - p. S37-S38 , 2023
Link: https://doi.org/10.1016/..
 
?
13

TIME TO SLEEP IMPROVEMENT IN PATIENTS WITH CHRONIC SPONTANE..:

Mosnaim, G. ; Holden, M. ; Trzaskoma, B...
Annals of Allergy, Asthma & Immunology.  131 (2023)  5 - p. S36 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Severe perioperative anaphylaxis: Incidence in a tertiary h..:

Escolano, F. ; Yelamos, J. ; Moltó, L....
Revista Española de Anestesiología y Reanimación (English Edition).  70 (2023)  1 - p. 17-25 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Daily Clinical Practice in the Management of Chronic Urtica..:

Ferrer Puga, M. ; Silvestre Salvador, J.F. ; Bartra Tomas, J....
Actas Dermo-Sifiliográficas.  113 (2022)  1 - p. 4-14 , 2022
Link: https://doi.org/10.1016/..
 
1-15